Your browser doesn't support javascript.
loading
Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus.
Chen, Zhang-Ren; Lv, Qiao-Li; Peng, Hong-Wei; Liu, Xiao-Yi; Hu, Wen-Lei; Hu, Jin-Fang.
Affiliation
  • Chen ZR; Department of pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China. Electronic address: chenzhangren@yeah.net.
  • Lv QL; Jiangxi Key Laboratory of Translational Cancer Research, Department of Head and Neck Surgery, Jiangxi Cancer Hospital of Nanchang University, Nanchang, China.
  • Peng HW; Department of pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Liu XY; Department of pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Hu WL; Department of pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Hu JF; Department of pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China. Electronic address: hujinfang333@126.com.
J Infect ; 86(2): 154-225, 2023 02.
Article in En | MEDLINE | ID: mdl-36442658
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Benzamides / Monkeypox virus Type of study: Diagnostic_studies / Screening_studies Language: En Journal: J Infect Year: 2023 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Benzamides / Monkeypox virus Type of study: Diagnostic_studies / Screening_studies Language: En Journal: J Infect Year: 2023 Type: Article